A5052841773- Analytical Methods in Pharmaceuticals
- Asthma and respiratory diseases
- Cancer Immunotherapy and Biomarkers
- Tissue Engineering and Regenerative Medicine
- Neuroendocrine Tumor Research Advances
- Nanoparticles: synthesis and applications
- Pesticide Residue Analysis and Safety
- Respiratory and Cough-Related Research
- Neuroblastoma Research and Treatments
- Statistical Methods in Clinical Trials
- Innovative Microfluidic and Catalytic Techniques Innovation
Weifang Medical University
2024
Qingdao University
2024
Qingdao Municipal Hospital
2024
United States Food and Drug Administration
2020
Rationale: Immunotherapy with immune checkpoint inhibitors (ICI) has shown promising activity against many tumor types. However, they can also induce a wide array of immune-related adverse events, ranging from mild to fatal. Primary 3 endocrine gland insufficiency during treatment ICI rarely been reported. Patient concerns: We report the case 33-year-old man Ewing sarcoma who was treated toripalimab as second-line treatment. Approximately 11 months after initiating treatment, patient...